Data as of Apr 17
 -0.17 / -1.97%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

MEI Pharma, Inc. is a development stage oncology company, which focuses on the clinical development of novel small molecules for the treatment of cancer. The company currently focuses on the clinical development of two drug candidates, ME-143 and ME-344. It was founded on December 1, 2000 and is headquartered in San Diego, CA.

Contact Information

MEI Pharma, Inc.
11975 El Camino Real
San Diego California 92130-2541
P:(858) 792-6300
Investor Relations:
(858) 369-7199



Mutual fund holders29.24%
Other institutional28.51%
Individual stakeholders27.27%

Top Executives

Daniel P. GoldPresident, Chief Executive Officer & Director
Thomas M. ZechChief Financial Officer & Secretary
Ofir MorenoVice President-Research & Development
Robert D. MassChief Medical Officer
Kelly PowellVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.